A Phase 4 interventional study of Sufentanil Sublingual Tablet System and Intravenous Patient-Controlled Analgesia with morfine in Analgesia, Post Operative Pain and Patient Satisfaction, sponsored by Hospital Central do Funchal. Completed at 1 site in Portugal. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-02-28.
Sponsored by Hospital Central do Funchal · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Pain, Postoperative with a site in Portugal — 2 open to participants now, 2 under way, none of them phase 3. Pain, Postoperative · Portugal.
Among the 12 studies in Pain, Postoperative with a site in Portugal, this one is the 7th largest by enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2019, is one of 5 in phase 4, and was the 9th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →2 of the 12 studies in Pain, Postoperative with a site in Portugal are open now. Recruiting first, the newest first:
Hospital Central do Funchal · Sites in Portugal
Ages 18+ · Women only · Healthy volunteers
Implantology Institute · Sites in Portugal
Healthy volunteers
A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 3 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 54 is below the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 60 across the 10 interventional studies, 180 across the 2 observational. Of the 7 that completed or were terminated, 3 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 12 have an industry lead sponsor. The 8 most frequent:
Hospital Central do Funchal is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Hospital Central do Funchal has 2 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 12 studies in Pain, Postoperative with a site in Portugal, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Patient-controlled intravenous analgesia (PCA) has already proven its quality. However, with new strategies starting to emerge and the current concept of opioid sparing, it is a goal to find the optimal PCA strategy capable of improve patient satisfaction and, at the same time, individualize opioid dose.
In a prospected randomized study, it was compared the use of Sufentanil Sublingual PCA System with intravenous PCA Morphine in terms of postoperative pain control satisfaction, total dose of opioid required, adverse effects, impact on the quality of postoperative recovery and the incidence of postoperative chronic pain.
In a prospected randomized study, it was compared the use of Sufentanil Sublingual PCA System (15mcg per tablet, 20 minutes lockout) with intravenous PCA Morphine based on 1mg morphine on-demand 10 minutes lockout and a baseline perfusion of 1mg/hour.
45 patients capable of comply a PCA regime submitted to total knee arthroplasty, total hip arthroplasty and abdominal hysterectomy were enrolled in the study. During the first 48 hours, it was accessed daily pain scores, PCA use, need for rescue therapy, adverse effects, global satisfaction as well as postoperative quality recovery. Brief Pain Inventory was performed before surgery and 4 months later.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Group treated with Sufentanil Sublingual Tablet System
Drug: Sufentanil Sublingual Tablet System
Group treated with intravenous Patient-Controlled Analgesia with Morphine
Drug: Intravenous Patient-Controlled Analgesia with morfine
Sufentanil Sublingual Tablet System is a sublingual opioid patient controlled analgesia system. It was used for postoperative analgesia after surgery associated with moderate to severe pain.
Also known as: zalviso
Intravenous Patient-Controlled Analgesia with morfine. It was used for postoperative analgesia after surgery associated with moderate to severe pain.
Postoperative pain control
Comparison between patient controlled analgesia with IV morphine and sublingual sufentanil in Numeric Rating Scale
Time frame: Evaluation at 24 hours and 48 hours after surgery
Adverse effects associated with analgesia
Evaluation of adverse effects of the PCA systems: sedation using the Richamond Agitation Sedation Scale (RASS); hypoxemia without oxygen supplementation: mild to moderate (SpO2 90-93%) or severe (SpO2\<90%); hypotension; nausea or vomiting; dyspepsia; itching
Time frame: Evaluation at 24 hours and 48 hours after surgery
Total daily dose of opioid
Evaluation of total daily dose of each drug
Time frame: Evaluation at 24 hours and 48 hours after surgery
Patients satisfaction with analgesia
Evaluation of patient satisfaction using a qualitative scale: "Poor"; "Average"; "Good"; "Excellent"
Time frame: Evaluation at 24 hours and 48 hours after surgery
Impact of the treatment on the quality of postoperative recovery
Evaluation of recovery with application of validated quality of recovery score (QoR-15) questionnaire
Time frame: Evaluation at 24 hours after surgery
Incidence of postoperative chronic pain
Assessment to persistent postoperative pain by completing the Brief Pain Inventory
Time frame: 4 months after surgey
Plan to share: Yes
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
No publications or documents are linked to this record.
Ran from Oct 2019 to primary completion in Jun 2020, 8 months.
Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's 8 months is below that.
Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Central do Funchal